Drug Information

Drug General Information
Drug ID
D0M4HV
Former ID
DAP000725
Drug Name
Lansoprazole
Synonyms
Agopton; Amarin; Aprazol; Bamalite; Blason; Compraz; Dakar; Ilsatec; Ketian; Lancid; Lanproton; Lansopep; Lansoprazol; Lansoprazolum; Lansox; Lanston; Lanz; Lanzo; Lanzol; Lanzopral; Lanzoprazole; Lanzor; Lanzul; Lasoprol; Limpidex; Mesactol; Monolitum; Ogast; Ogastro; Opiren; PrevOnco; Prevacid; Prezal; Promeco;Promp; Prosogan; Suprecid; Takepron; Ulpax; Zoprol; Zoton; Abbot Brand of Lansoprazole; Almirall Brand of Lansoprazole; Biuret Gr; Biuret Reagent Solution; Hoechst Brand of Lansoprazole; Hormona Brand of Lansoprazole; Lansoprazole sulphone; Lederle Brand of Lansoprazole; Prevacid Iv; Prevacid SoluTab; Pro Ulco; Promeco Brand of Lansoprazole; Salvar Brand of Lansoprazole; TAP Brand of Lansoprazole; Takeda Brand of Lansoprazole; Tecnobio Brand of Lansoprazole; Vinas Brand of Lansoprazole; Wyeth Brand of Lansoprazole; A 65006; AG 1749; L 8533; TAK 390MR; TAK390MR; A-65006; ABT-006; AG-1749; Agopton (TN); CG-4801; Lansoprazol [INN-Spanish]; Lansoprazolum [INN-Latin]; Lansox (TN); Lanzol-30; Ogast (TN); Prevacid (TN); Prevacid I.V; TAK-390MR; Takepron (TN); Lansoprazole [USAN:BAN:INN]; Prevacid I.V.; Lansoprazole (JAN/USP/INN); Prevacid, Prevacid NapraPAC, Prevacid SoluTab, Lansoprazole; 2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole; 2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole; 2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)-1H-benzimidazole; 2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole; 2-[({3-methyl-4-[(2,2,2-trifluoroethyl)oxy]pyridin-2-yl}methyl)sulfinyl]-1H-benzimidazole; 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole; 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl] methyl] sulfinyl] benzimidazole; 2-[[[3-methyl-4-(2,2,2-trifluroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole
Drug Type
Small molecular drug
Indication Peptic ulcer [ICD9: 531-534; ICD10:K25-K27] Approved [535862], [542222]
Nsaid-related gastric ulcer [ICD9: 531; ICD10:K25] Phase 3 [535862], [542222]
Therapeutic Class
Antiulcer Agents
Company
Takeda
Structure
Download
2D MOL

3D MOL
Formula
C16H14F3N3O2S
InChI
InChI=1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)/t25-/m1/s1
InChIKey
MJIHNNLFOKEZEW-RUZDIDTESA-N
CAS Number
CAS 103577-45-3
PubChem Compound ID
9578005
PubChem Substance ID
14901842, 15375021, 23998121, 25819922, 44715913, 80665304, 89736101, 96025586, 104179070, 104234371, 126682042, 128604168, 135156589, 137931058, 140767605, 162189572, 164178109, 164761527, 170503333, 175265917, 175269426, 175611039, 178102134, 184527042, 185965235, 210274918, 210280553, 223658647, 223798807, 226429139, 241033947, 251879797, 252151427, 252431524, 252811271
ChEBI ID
ChEBI:6375
SuperDrug ATC ID
A02BC03
SuperDrug CAS ID
cas=103577453
Target and Pathway
Target(s) H+ K+ ATPase Target Info Modulator [556264]
References
Ref 535862An overview of proton pump inhibitors. Gastroenterol Nurs. 2003 Sep-Oct;26(5):182-90.
Ref 542222(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7208).
Ref 556264Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.